SecBot SecBot
SECBOTREPLAY Home › Report › LGND

LGND · Two insiders at Ligand Pharmaceuticals sold a combined $427K in…

LIGAND PHARMACEUTICALS INC · CLUSTER filed Sep 14, 2026 at 16:59 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Sep 14, 2026 at 16:59 ET

Two insiders at Ligand Pharmaceuticals sold a combined $427K in open-market transactions over a one-week window. The sales are small relative to the $5.7B market cap (0.007%), and the cluster consists of a CLO and a director, not the CEO or CFO, limiting the informational signal.

  • Two insiders sold shares between Sept 3 and Sept 10, 2026
  • Total sale value: $427K (0.007% of $5.7B market cap)
  • Sellers: CLO Andrew Reardon ($85K) and Director Martine Zimmermann ($342K)
  • No CEO or CFO sales in the cluster

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access